EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Post-Operative Analgesic Protocols Following Tonsillectomy: Balancing Efficacy and Safety

Journal of Surgical Radiology · 30.06.2026 · 5 (6) · 531-536

DOI: 10.61336/jsr/26-06-74 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Radiology, online erschienen am 30.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tonsillectomy remains a ubiquitous surgical procedure globally, yet the management of post-operative pain continues to pose a formidable clinical challenge. The unique neuroanatomy of the tonsillar fossa, coupled with the secondary inflammatory cascade induced by eschar sloughing, generates a biphasic pain profile that is notoriously difficult to manage. The historical reliance on opioid analgesia is increasingly restricted due to the dual threats of respiratory depression and post-operative nausea and vomiting (PONV). Furthermore, the use of traditional non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is often hindered by surgical concerns regarding secondary hemorrhage.

Objective

To prospectively evaluate the analgesic efficacy, opioid-sparing potential, and hemocoagulative safety profile of a highly selective COX-2 inhibitor (Celecoxib) compared to an atypical opioid (Tramadol) when integrated into a standard acetaminophen backbone following adult tonsillectomy.

Methods

This prospective, randomized, parallel-group clinical study was conducted within the Department of Otorhinolaryngology. A standardized cohort of 85 adult patients scheduled for elective bilateral tonsillectomy was randomized into two groups. Group A (n=43) received Acetaminophen + Celecoxib, while Group B (n=42) received Acetaminophen + Tramadol for 7 days post-operatively. The primary endpoint was the Visual Analogue Scale (VAS) score during deglutition. Secondary endpoints included cumulative rescue medication requirements, PONV incidence, and rates of primary/secondary post-tonsillectomy hemorrhage (PTH).

Results

Group A demonstrated superior analgesic efficacy during the late inflammatory phase (Days 4-7), with significantly lower mean VAS scores upon swallowing (p < 0.05). Consequently, Group A required 40% less rescue analgesia than Group B. The incidence of moderate-to-severe PONV was significantly higher in the Tramadol cohort (21.4%) compared to the Celecoxib cohort (4.6%). Crucially, there was no statistically significant difference in the incidence of post-operative hemorrhage between the two cohorts.

Conclusion

A multimodal analgesic protocol utilizing a COX-2 specific inhibitor provides superior, sustained pain relief during the critical eschar sloughing phase of tonsillectomy recovery. By selectively targeting the inflammatory cascade without inhibiting platelet thromboxane synthesis, Celecoxib aggressively mitigates pain and reduces opioid reliance while preserving absolute surgical hemostasis, thereby optimizing the balance between efficacy and safety

Zitieren

APA

(2026). Evaluation of Post-Operative Analgesic Protocols Following Tonsillectomy: Balancing Efficacy and Safety. Journal of Surgical Radiology, 5(6), 531-536. https://doi.org/10.61336/jsr/26-06-74

Vancouver

Evaluation of Post-Operative Analgesic Protocols Following Tonsillectomy: Balancing Efficacy and Safety. Journal of Surgical Radiology. 2026;5(6):531-536. doi:10.61336/jsr/26-06-74

BibTeX
@article{euvimed2026,
  title = {Evaluation of Post-Operative Analgesic Protocols Following Tonsillectomy: Balancing Efficacy and Safety},
  journal = {Journal of Surgical Radiology},
  year = {2026},
  volume = {5},
  number = {6},
  pages = {531--536},
  doi = {10.61336/jsr/26-06-74}
}
Kostenlos starten →